Literature DB >> 15920985

Dosimetry parameters of BARC OcuProsta I-125 seed source.

S D Sharma1, M Basu, A Shanta, T Palani Selvam, U B Tripathi, B C Bhatt.   

Abstract

A new model of 125I seed source, named OcuProsta seed, was designed and fabricated by Radiopharmaceuticals Division of Bhabha Atomic Research Centre for ophthalmic and interstitial applications. AAPM TG 43 recommended dosimetry parameters for this seed source were determined experimentally using TLD as well as by Monte Carlo (MC) simulation. Measured and MC calculated values of the dose rate constant (DRC) are 0.95 +/- 0.065 cGyh(-1)U(-1) and 0.972 +/- 0.005 cGyh(-1)U(-1), respectively. The mean of measured and calculated DRC (lambda = 0.96 cGyh(-1)U(-1)) was recommended for the clinical dosimetry of OcuProsta seed. Measured and MC calculated radial dose function, g(r), anisotropy function, F(r,theta), anisotropy factor and anisotropy constants are also found to be in good agreement to each other. Dosimetry parameters of OcuProsta seed were compared with the published values of similar in-design 125I seed sources. The DRC of BARC OcuProsta seed is very close to Amersham 6711 seed and is also comparable to the DRC of Best model 2301, Syncor PharmaSeed and Isotron selectSeed within the uncertainty of measurement/calculation. The g(r) of OcuProsta seed shows a difference of up to 10% in comparison to the g(r) values of the similar in-design seed sources. The values of anisotropy function of OcuProsta are 7-13% different from the anisotropy function of Amersham 6711 and Syncor PharmaSeed. The anisotropy constant of OcuProsta is close to Amersham 6711 seed while it is about 9% smaller than the anisotropy constant of Best model 2301 and Synchor PharmaSeed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920985     DOI: 10.1007/BF03178859

Source DB:  PubMed          Journal:  Australas Phys Eng Sci Med        ISSN: 0158-9938            Impact factor:   1.430


  4 in total

1.  Evaluation of Gafchromic EBT2 film for the measurement of anisotropy function for high-dose-rate (192)Ir brachytherapy source with respect to thermoluminescent dosimetry.

Authors:  Satish C Uniyal; Umesh C Naithani; Sunil D Sharma
Journal:  Rep Pract Oncol Radiother       Date:  2010-12-07

2.  An EGSnrc investigation of the air-kerma strength, dose rate constant, and radial dose function of 125I brachytherapy sources.

Authors:  Sridhar Sahoo; T Palani Selvam
Journal:  Radiol Phys Technol       Date:  2009-07-11

3.  Episcleral plaque brachytherapy using 'BARC I-125 Ocu-Prosta seeds' in the treatment of intraocular tumors: a single-institution experience in India.

Authors:  Parag K Shah; V Narendran; U Selvaraj; P Guhan; Sanjay K Saxena; Ashutosh Dash; Melvin Astrahan
Journal:  Indian J Ophthalmol       Date:  2012-07       Impact factor: 1.848

4.  Validation of American Association of Physicists in Medicine TG 43 Dosimetry Data in Commercial Treatment Planning System.

Authors:  Sathiyan Saminathan; K Maheshraja; K M Ganesh
Journal:  J Med Phys       Date:  2021-09-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.